Enhancement of antigenic potency in vitro and immunogenicity in vivo by coupling the antigen to anti-immunoglobulin
- PMID: 3079611
Enhancement of antigenic potency in vitro and immunogenicity in vivo by coupling the antigen to anti-immunoglobulin
Abstract
We have examined the effect of targeting an antigen to the immune system, by covalently coupling it to anti-immunoglobulin (Ig), on its efficacy for T cell stimulation in vitro and its immunogenicity for antibody production in vivo. In vitro, we compared the potency (for stimulation of a ferritin-specific T cell line) of free ferritin, ferritin coupled to goat antimouse IgM (heavy (H) chain specific), ferritin coupled to anti-IgG (H and light (L) chain specific), or ferritin coupled to anti-IgA (H chain specific), as well as a mixture of free ferritin plus goat anti-IgG. The ferritin coupled to anti-IgM or to anti-IgG (H + L), which could bind to surface Ig of B cells, stimulated T cell proliferation at concentrations of ferritin at least 10-fold lower than those required for the other forms of the antigen over the entire time course of the response, with 1000 rad-irradiated spleen cells as presenting cells. Because the goat antibodies were all of the same IgG isotype and coupling ratio, the failure of goat anti-IgA to enhance potency served as a control to exclude Fc receptor binding as the mechanism. The effect was not due to the nonspecific activation of B cells to become more efficient antigen-presenting cells, because mixtures of ferritin plus anti-IgG (H + L) had no effect, and the anti-IgG coupled to ferritin did not enhance presentation of myoglobin to a myoglobin-specific T cell line. The enhanced presentation of ferritin conjugated to goat anti-IgG (H + L) or to anti-IgM was sensitive to radiation doses greater than 2000 R, and was effective at less than one-tenth the number of spleen cells, consistent with the predominance of B cells as antigen-presenting cells for this form of the antigen rather than macrophages and dendritic cells only. When B cells and accessory cells were purified from T-depleted spleen cells, only the B cell preparation but not the accessory cell population manifested enhanced presentation of ferritin coupled to anti-IgG compared with free ferritin, and it was radiosensitive. Finally, allogeneic B cells could not mediate the enhancement in the presence of syngeneic splenic accessory cells (SAC); therefore, the enhancement was not due to shedding of immune complexes from B cells and subsequent presentation by SAC. We conclude that targeting the antigen to B cells as presenting cells greatly enhances its efficacy in vitro.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Antibody conjugates mimic specific B cell presentation of antigen: relationship between T and B cell specificity.J Immunol. 1987 Jun 15;138(12):4133-42. J Immunol. 1987. PMID: 2438335
-
Immunoglobulin-specific T-B cell interaction. I. Presentation of self immunoglobulin determinants by B lymphocytes.Eur J Immunol. 1989 Sep;19(9):1677-83. doi: 10.1002/eji.1830190923. Eur J Immunol. 1989. PMID: 2477255
-
Receptor-mediated B cell antigen processing. Increased antigenicity of a globular protein covalently coupled to antibodies specific for B cell surface structures.J Immunol. 1988 Jan 15;140(2):404-10. J Immunol. 1988. PMID: 2447176
-
Changes in specific B cells and the dissemination of the primed state in vivo following antigenic stimulation by different mucosal routes.Ann Allergy. 1984 Dec;53(6 Pt 2):541-9. Ann Allergy. 1984. PMID: 6209998 Review.
-
Antigen presentation by B lymphocytes to CD4+ T lymphocytes in vivo: importance for B lymphocyte and T lymphocyte activation.Semin Immunol. 1992 Aug;4(4):247-55. Semin Immunol. 1992. PMID: 1356502 Review.
Cited by
-
Dendritic cell targeted Ccl3- and Xcl1-fusion DNA vaccines differ in induced immune responses and optimal delivery site.Sci Rep. 2019 Feb 12;9(1):1820. doi: 10.1038/s41598-018-38080-7. Sci Rep. 2019. PMID: 30755656 Free PMC article.
-
Targeted DNA vaccines for enhanced induction of idiotype-specific B and T cells.Front Oncol. 2012 Oct 30;2:154. doi: 10.3389/fonc.2012.00154. eCollection 2012. Front Oncol. 2012. PMID: 23115759 Free PMC article.
-
DNA Vaccines: Their Formulations, Engineering and Delivery.Vaccines (Basel). 2024 Jan 11;12(1):71. doi: 10.3390/vaccines12010071. Vaccines (Basel). 2024. PMID: 38250884 Free PMC article. Review.
-
Immunogenic targeting of recombinant peptide vaccines to human antigen-presenting cells by chimeric anti-HLA-DR and anti-surface immunoglobulin D antibody Fab fragments in vitro.J Virol. 1995 Apr;69(4):2357-65. doi: 10.1128/JVI.69.4.2357-2365.1995. J Virol. 1995. PMID: 7533857 Free PMC article.
-
DNA vaccines: MHC II-targeted vaccine protein produced by transfected muscle fibres induces a local inflammatory cell infiltrate in mice.PLoS One. 2014 Oct 9;9(10):e108069. doi: 10.1371/journal.pone.0108069. eCollection 2014. PLoS One. 2014. PMID: 25299691 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous